Latest Stories
3 Reasons We Love Insulet (PODD)
Since May 2025, Insulet has been in a holding pattern, posting a small return of 3% while floating around $335.74. The stock also fell short of the S&P 500’s 11.9% gain during that period.
3 Reasons to Sell SGRY and 1 Stock to Buy Instead
Surgery Partners has gotten torched over the last six months - since May 2025, its stock price has dropped 35.6% to $15.19 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
nLIGHT (LASR): Buy, Sell, or Hold Post Q3 Earnings?
nLIGHT has been on fire lately. In the past six months alone, the company’s stock price has rocketed 126%, reaching $28.61 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings?
What a brutal six months it’s been for Health Catalyst. The stock has dropped 44.2% and now trades at $2.18, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
2 Reasons to Like YUM and 1 to Stay Skeptical
Yum! Brands has been treading water for the past six months, recording a small loss of 0.6% while holding steady at $148.81. The stock also fell short of the S&P 500’s 11.9% gain during that period.
NerdWallet (NRDS): Buy, Sell, or Hold Post Q3 Earnings?
NerdWallet has had an impressive run over the past six months as its shares have beaten the S&P 500 by 8.1%. The stock now trades at $13.51, marking a 20% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Avoid TXG and 1 Stock to Buy Instead
What a time it’s been for 10x Genomics. In the past six months alone, the company’s stock price has increased by a massive 73.9%, reaching $15.53 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Upwork (UPWK): 3 Reasons We Love This Stock
Upwork has been treading water for the past six months, recording a small return of 4.5% while holding steady at $17.29. The stock also fell short of the S&P 500’s 11.9% gain during that period.
3 Reasons to Sell ILMN and 1 Stock to Buy Instead
Illumina has been on fire lately. In the past six months alone, the company’s stock price has rocketed 47%, reaching $121.93 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons LW is Risky and 1 Stock to Buy Instead
Lamb Weston has been treading water for the past six months, recording a small return of 4.7% while holding steady at $56.06. The stock also fell short of the S&P 500’s 11.9% gain during that period.